Search

everythinglearnresearchcommunity

for

Search:↓

Fullerenes show potential in skin care but need more safety research.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Hair follicles could be used to noninvasively monitor our body's internal clock and help identify risks for related diseases.

Hormone testing may not be very helpful in diagnosing female pattern hair loss.

The supplement with Myo-inositol and D-chiro-inositol improves metabolic symptoms in PCOS, especially when combined with metformin.

Hypothyroidism may worsen metabolic problems like insulin resistance and obesity in women with PCOS.

The book helps veterinarians understand and treat hair loss in animals.

Women with female pattern hair loss may have a higher risk of metabolic syndrome.

Premature graying and hair changes can be treated with certain peptides and possibly targeting the endocannabinoid system.

Researchers successfully isolated and identified key markers of stem cell-enriched human hair follicle bulge cells.

Japanese vitiligo patients and their families often have other autoimmune diseases.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Venlafaxine can cause hair loss, which stops after discontinuation.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

A young Saudi girl with uncontrolled type 1 diabetes and hypothyroidism had two rare conditions, Mauriac syndrome and Van Wyk–Grumbach syndrome.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Hormones significantly influence hair growth, with conditions like hirsutism and patterned hair loss linked to hormone levels; more research is needed for full understanding.

Psoriasis is linked to a higher risk of autoimmune diseases and other health conditions.

The skin acts like an endocrine organ, producing hormones that affect various body functions and skin health, and understanding this can lead to new treatments.